164 related articles for article (PubMed ID: 36835857)
1. Platelet-Rich Plasma Improves Pregnancy Outcomes in Moderate to Severe Intrauterine Adhesion: A Retrospective Cohort Study.
Qiu D; Xiao X; Wang W; Zhang W; Wang X
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835857
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of autologous platelet-rich plasma in preventing adhesion reformation following hysteroscopic adhesiolysis: a randomized controlled trial.
Shen M; Duan H; Lv R; Lv C
Reprod Biomed Online; 2022 Dec; 45(6):1189-1196. PubMed ID: 36184275
[TBL] [Abstract][Full Text] [Related]
3. Platelet-rich plasma in the management of Asherman's syndrome: An RCT.
Javaheri A; Kianfar K; Pourmasumi S; Eftekhar M
Int J Reprod Biomed; 2020 Feb; 18(2):113-120. PubMed ID: 32259005
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis on the use of hyaluronic acid gel to prevent recurrence of intrauterine adhesion after hysteroscopic adhesiolysis.
Fei Z; Bin Z; Xin X; Fei H; Yuechong C
Taiwan J Obstet Gynecol; 2019 Nov; 58(6):731-736. PubMed ID: 31759520
[TBL] [Abstract][Full Text] [Related]
5. A matched cohort study comparing the outcome of intrauterine adhesiolysis for Asherman's syndrome after uterine artery embolization or surgical trauma.
Song D; Liu Y; Xiao Y; Li TC; Zhou F; Xia E
J Minim Invasive Gynecol; 2014; 21(6):1022-8. PubMed ID: 24842805
[TBL] [Abstract][Full Text] [Related]
6. Intrauterine administration of G-CSF for promoting endometrial growth after hysteroscopic adhesiolysis: a randomized controlled trial.
Zhang Y; Chen X; Chen S; Wei C; Li B; Wang Z; Shen X; Lin X
Hum Reprod; 2022 Apr; 37(4):725-733. PubMed ID: 35147195
[TBL] [Abstract][Full Text] [Related]
7. Autologous platelet-rich plasma treatment for moderate-severe Asherman syndrome: the first experience.
Aghajanova L; Sundaram V; Kao CN; Letourneau JM; Manvelyan E; Cedars MI; Huddleston HG
J Assist Reprod Genet; 2021 Nov; 38(11):2955-2963. PubMed ID: 34613578
[TBL] [Abstract][Full Text] [Related]
8. Oxidized, Regenerated Cellulose Adhesion Barrier Plus Intrauterine Device Prevents Recurrence After Adhesiolysis for Moderate to Severe Intrauterine Adhesions.
Cai H; Qiao L; Song K; He Y
J Minim Invasive Gynecol; 2017 Jan; 24(1):80-88. PubMed ID: 27742483
[TBL] [Abstract][Full Text] [Related]
9. Platelet-rich plasma for the management of intrauterine adhesions: A systematic review and meta-analysis of randomized controlled trials.
Albazee E; Al-Rshoud F; Almahmoud L; Al Omari B; Alnifise M; Baradwan S; Abu-Zaid A
J Gynecol Obstet Hum Reprod; 2022 Feb; 51(2):102276. PubMed ID: 34856385
[TBL] [Abstract][Full Text] [Related]
10. Platelet-rich plasma improves therapeutic effects of menstrual blood-derived stromal cells in rat model of intrauterine adhesion.
Zhang S; Li P; Yuan Z; Tan J
Stem Cell Res Ther; 2019 Feb; 10(1):61. PubMed ID: 30770774
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of autologous platelet-rich plasma therapy for intrauterine adhesions: a systematic review and meta-analysis.
Tang R; Xiao X; He Y; Qiu D; Zhang W; Wang X
Front Endocrinol (Lausanne); 2023; 14():1183209. PubMed ID: 37484965
[TBL] [Abstract][Full Text] [Related]
12. In vitro fertilization and embryo transfer may improve live birth rate for patients with intrauterine adhesions after hysteroscopic adhesiolysis.
Sun D; Zhao X; Huang H; Zhang A; Cheng W; Yang Y; Xu D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 47(11):1559-1567. PubMed ID: 36481634
[TBL] [Abstract][Full Text] [Related]
13. Comparison of therapeutic efficacy of three methods to prevent re-adhesion after hysteroscopic intrauterine adhesion separation: a parallel, randomized and single-center trial.
Zhang X; Liu W; Zhou Y; Qiu J; Sun Y; Li M; Ding Y; Xi Q
Ann Palliat Med; 2021 Jun; 10(6):6804-6823. PubMed ID: 34237979
[TBL] [Abstract][Full Text] [Related]
14. Effect of intrauterine infusion of platelet-rich plasma for women with recurrent implantation failure: a systematic review and meta-analysis.
Deng H; Wang S; Li Z; Xiao L; Ma L
J Obstet Gynaecol; 2023 Dec; 43(1):2144177. PubMed ID: 36397660
[TBL] [Abstract][Full Text] [Related]
15. Reproductive Outcome of Patients with Asherman's Syndrome: A SAIMS Experience.
Bhandari S; Bhave P; Ganguly I; Baxi A; Agarwal P
J Reprod Infertil; 2015; 16(4):229-35. PubMed ID: 27110522
[TBL] [Abstract][Full Text] [Related]
16. [Effects of early intervention of second-look office hysteroscopy in the prevention of adhesion reformation for moderate-severe Asherman's syndrome].
Li C; Wei ML; Lin XN; Huang QX; Huang D; Zhang SY
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(45):3617-9. PubMed ID: 24534315
[TBL] [Abstract][Full Text] [Related]
17. Intrauterine Infusion of Human Platelet-Rich Plasma Improves Endometrial Regeneration and Pregnancy Outcomes in a Murine Model of Asherman's Syndrome.
Kim JH; Park M; Paek JY; Lee WS; Song H; Lyu SW
Front Physiol; 2020; 11():105. PubMed ID: 32116803
[TBL] [Abstract][Full Text] [Related]
18. Hysteroscopic adhesiolysis for patients with Asherman's syndrome: menstrual and fertility outcomes.
Yamamoto N; Takeuchi R; Izuchi D; Yuge N; Miyazaki M; Yasunaga M; Egashira K; Ueoka Y; Inoue Y
Reprod Med Biol; 2013 Oct; 12(4):159-166. PubMed ID: 29662367
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Reproductive Outcome Between 2 and 4 mg Daily Doses of Estradiol After Hysteroscopic Adhesiolysis: A Propensity Score Matching Analysis-Retrospective Cohort Study.
Qiu DE; Zhang WL; Liu J; Yang F; Miao Y; Tong YF; Xiao XF; Wang XH
Front Endocrinol (Lausanne); 2022; 13():775755. PubMed ID: 35769083
[TBL] [Abstract][Full Text] [Related]
20. Clinical study on 2 types of intrauterine stents with different thickness and hardness in the treatment of moderate-to-severe intrauterine adhesions.
Huang H; Mao X; Yu Y; Xiao B; Zhao X; Zhang A; Xu D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 47(11):1575-1585. PubMed ID: 36481636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
